This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Third Time Was No Charm, FDA Denies Amarin Vascepa SPA Appeal

09/12/14 - 09:43 AM EDT

Amarin evaluating next steps following FDA's decision to denial reinstatement of Vascepa SPA for 'Anchor" indication.

READ FULL POST

Orexigen's Obesity Pill is Approved and Stock Falls. Don't be Surprised

09/11/14 - 01:23 PM EDT

Orexigen's Contrave must prove it can top the dismal obesity pill launches of its competitors Arena and Vivus.

READ FULL POST

Medivation Prostate Cancer Drug Secures Expanded FDA Label

09/10/14 - 03:37 PM EDT

Language in the new Xtandi label should help Medivation and Astellas widen their market share lead over Johnson & Johnson's competing prostate cancer drug Zytiga.

READ FULL POST

J.P. Morgan Biotech Analyst Meacham Exits for New Barclays Gig

09/08/14 - 08:48 AM EDT

Meacham is taking a new job at Barclays where he will cover biotech and pharma stocks.

READ FULL POST

Google Healthcare Startup Calico Partners With Abbvie

09/03/14 - 01:19 PM EDT

Under the agreement, Calico and Abbvie will work together to discover and develop new drugs for age-related diseases, including neuro-degeneration and cancer.

READ FULL POST

Sunesis Takes a Run Through the Feuerstein-Ratain Rule

09/02/14 - 10:29 AM EDT

Results from Sunesis' phase III study in acute myeloid leukemia should be released this month or next.

READ FULL POST

Biotech Stock Boom Times Are Back

08/26/14 - 07:00 AM EDT

The iShares Nasdaq Biotechnology ETF closed at 272.63 Monday, less than one point below the year (and all-time) closing high reached on Feb. 25.

READ FULL POST

Galena Fires CEO Ahn, Offers No Parting Gifts

08/25/14 - 08:48 AM EDT

CEOs who leave companies on good terms get cushy severance packages. Galena's Ahn did not.

READ FULL POST

Ampio: The Freezer Killed My Osteoarthritis Drug

08/21/14 - 10:23 AM EDT

Ampio Pharmaceuticals is blaming a mini Polar Vortex for blowing up a pivotal study of its osteoarthritis drug Ampion.

READ FULL POST

Northwest Bio Can't Keep Its DC-Vax Claims Straight

08/14/14 - 10:20 AM EDT

Contradictory statements made on whether or not Northwest Bio conducted an interim analysis of its DC-Vax phase III study.

READ FULL POST

Markets

DOW 18,093.89 +55.92 0.31%
S&P 500 2,114.46 +5.54 0.26%
NASDAQ 5,055.2170 -5.0290 -0.10%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs